The potential benefits of DCTs are often highlighted: improved participant retention, greater representativeness, reduced costs, and a smaller carbon footprint. What did we find as drivers for these KPIs?
Participant accessibility and representativeness
Participant accessibility and representativeness
DCTs have significant potential to reduce logistical barriers and improve accessibility. This can enable the participation of traditionally underserved populations, ensuring that findings are applicable to more segments of the population…
Retention in a clinical trial refers to the number or proportion of participants who complete the study through to the end. The ease of participation in a DCT may improve retention as continued participation may be more flexibly managed around…
It has been reported that the pharmaceutical industry is among the highest producers of greenhouse gas emissions. Carbon footprinting can be used to identify which elements of DCTs have the greatest impact on greenhouse gas emissions…
Setting up and conducting clinical trials is costly, and some have raised concerns that expenditures may increase. Introducing DCT elements could further increase clinical trial costs, particularly for technology set-up and online recruitment methods…
